Dr. Lal PathLabs Limited
LALPATHLAB
Classifica tra le azioni
#4510
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Prezzo delle azioni
$20.36
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$3.40B
Variazione (1 giorno)
-0.80%
Variazione (1 anno)
13.69%
Paese
IN
Scambia Dr. Lal PathLabs Limited (LALPATHLAB)
Categoria
Healthcare
Utile per Dr. Lal PathLabs Limited (LALPATHLAB)
Utile nel Jun 2026 TTM: $79.09M
Secondo gli ultimi rapporti finanziari di Dr. Lal PathLabs Limited, gli utili attuali della società sono $79.09M. Nel 2024, la società ha registrato un utile di $60.62M, un aumento rispetto a agli utili del 2023, che erano di $41.84M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Dr. Lal PathLabs Limited dal 2011 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $79.09M | 8.27% |
| 2025 | $73.05M | 20.51% |
| 2024 | $60.62M | 44.89% |
| 2023 | $41.84M | -33.14% |
| 2022 | $62.57M | 16.14% |
| 2021 | $53.88M | 30.72% |
| 2020 | $41.22M | -4.77% |
| 2019 | $43.28M | 7.84% |
| 2018 | $40.13M | 9.90% |
| 2017 | $36.52M | 20.54% |
| 2016 | $30.30M | 35.31% |
| 2015 | $22.39M | -3.94% |
| 2014 | $23.31M | 57.92% |
| 2013 | $14.76M | 12.68% |
| 2012 | $13.10M | 30.51% |
| 2011 | $10.04M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $7.61B | 9,520.18% |
US
|
|
| $4.76B | 5,920.67% |
US
|
|
| $-252.70M | -419.49% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 1,996.24% |
US
|
